Research Interests
Medical education; Wellness; Fellowships and EPAs; Pediatric HIV; Coaching
Selected Grants
A Phase 2/3, Open-Label Study of t and Childrenhe Pharmacokinetics, Safety, and Antiviral Activity of the GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) Fixed Dose Combination (FDC) in HIV-1
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2017 - 2027Wake County Ryan White Part B
Public ServicePrincipal Investigator · Awarded by Wake County Human Services · 2018 - 2027Ryan White HIV/AIDS Program Part D Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth (WICY)
Public ServicePrincipal Investigator · Awarded by Health Resources and Service Administration · 2010 - 2026A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine/Islatravir in Adolescents with HIV-1 Infection who are Virologically Suppressed, are >-12 to <18 Years of Age, and Weigh >-35 kg
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2020 - 2023HIV Pediatric Services
Public ServicePhysician · Awarded by Wake County Human Services · 2012 - 2015CORE / DUMC Pediatric Clinical Research Site (CRS) 1U01AI69484-01
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2007 - 2013HIV/AIDS Clinical Trials Unit (IMPAACT CTU)
ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2008IMPAACT CTU
ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2008External Relationships
- APPD SPIN (Association for Pediatric Program Directors Subspecialty Pediatric Investigator network)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.